These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 11907160)
21. Prevention of naphthalene-induced pulmonary toxicity by glutathione prodrugs: roles for glutathione depletion in adduct formation and cell injury. Phimister AJ; Nagasawa HT; Buckpitt AR; Plopper CG J Biochem Mol Toxicol; 2005; 19(1):42-51. PubMed ID: 15736154 [TBL] [Abstract][Full Text] [Related]
22. Effect of ribose cysteine pretreatment on hepatic and renal acetaminophen metabolite formation and glutathione depletion. Slitt AM; Dominick PK; Roberts JC; Cohen SD Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):487-94. PubMed ID: 15910414 [TBL] [Abstract][Full Text] [Related]
23. Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferase. Morgan AS; Sanderson PE; Borch RF; Tew KD; Niitsu Y; Takayama T; Von Hoff DD; Izbicka E; Mangold G; Paul C; Broberg U; Mannervik B; Henner WD; Kauvar LM Cancer Res; 1998 Jun; 58(12):2568-75. PubMed ID: 9635580 [TBL] [Abstract][Full Text] [Related]
24. In vitro evaluation of novel N-acetylalaninate prodrugs that selectively induce apoptosis in prostate cancer cells. McGoldrick CA; Jiang YL; Brannon M; Krishnan K; Stone WL BMC Cancer; 2014 Sep; 14():675. PubMed ID: 25234292 [TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationships for 4-nitrobenzyl carbamates of 5-aminobenz[e]indoline minor groove alkylating agents as prodrugs for GDEPT in conjunction with E. coli nitroreductase. Hay MP; Atwell GJ; Wilson WR; Pullen SM; Denny WA J Med Chem; 2003 Jun; 46(12):2456-66. PubMed ID: 12773049 [TBL] [Abstract][Full Text] [Related]
26. The effect of modulation of glutathione cellular content on busulphan-induced cytotoxicity on hematopoietic cells in vitro and in vivo. Hassan Z; Hellström-Lindberg E; Alsadi S; Edgren M; Hägglund H; Hassan M Bone Marrow Transplant; 2002 Aug; 30(3):141-7. PubMed ID: 12189531 [TBL] [Abstract][Full Text] [Related]
27. Renal cellular transport, metabolism, and cytotoxicity of S-(6-purinyl)glutathione, a prodrug of 6-mercaptopurine, and analogues. Lash LH; Shivnani A; Mai J; Chinnaiyan P; Krause RJ; Elfarra AA Biochem Pharmacol; 1997 Dec; 54(12):1341-9. PubMed ID: 9393677 [TBL] [Abstract][Full Text] [Related]
28. Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene. Chen L; Waxman DJ; Chen D; Kufe DW Cancer Res; 1996 Mar; 56(6):1331-40. PubMed ID: 8640822 [TBL] [Abstract][Full Text] [Related]
30. Decreased cytotoxicity and increased antimitotic activity of a proline analogue of chlorambucil as a prodrug susceptible to the action of fibroblast's prolidase. Bielawska A; Chrzanowski K; Bielawski K; Pałka J Pharmazie; 2001 Apr; 56(4):290-4. PubMed ID: 11338665 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model. Neuwelt EA; Pagel MA; Hasler BP; Deloughery TG; Muldoon LL Cancer Res; 2001 Nov; 61(21):7868-74. PubMed ID: 11691805 [TBL] [Abstract][Full Text] [Related]
32. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells. Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220 [TBL] [Abstract][Full Text] [Related]
33. Desulfuration of 6-mercaptopurine. The basis for the paradoxical cytotoxicity of thiopurines in cultured human leukemic cells. Adamson PC; Balis FM; Hawkins ME; Murphy RF; Poplack DG Biochem Pharmacol; 1993 Nov; 46(9):1627-36. PubMed ID: 8240420 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy. Atwell GJ; Yang S; Pruijn FB; Pullen SM; Hogg A; Patterson AV; Wilson WR; Denny WA J Med Chem; 2007 Mar; 50(6):1197-212. PubMed ID: 17326614 [TBL] [Abstract][Full Text] [Related]
36. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione. Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092 [TBL] [Abstract][Full Text] [Related]
37. Importance of a hypervariable active-site residue in human Mu class glutathione transferases catalyzing the bioactivation of chemotherapeutic thiopurine prodrugs. Eklund BI; Mannervik B Biochim Biophys Acta; 2007 Aug; 1770(8):1098-103. PubMed ID: 17493759 [TBL] [Abstract][Full Text] [Related]
38. 5-Fluoroindole-3-acetic acid: a prodrug activated by a peroxidase with potential for use in targeted cancer therapy. Folkes LK; Greco O; Dachs GU; Stratford MR; Wardman P Biochem Pharmacol; 2002 Jan; 63(2):265-72. PubMed ID: 11841802 [TBL] [Abstract][Full Text] [Related]